| 1,3-thiazolidine-2,4-dione | increases expression | EXP | | 6480464 | 2,4-thiazolidinedione results in increased expression of SLC2A4 mRNA | CTD | PMID:20724125 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of SLC2A4 mRNA | CTD | PMID:15576828 |
| 17beta-estradiol | increases expression | ISO | RGD:731478 | 6480464 | Estradiol results in increased expression of SLC2A4 mRNA | CTD | PMID:19432593 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:731478 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC2A4 mRNA | CTD | PMID:17107852 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731479 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC2A4 mRNA | CTD | PMID:16615095 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC2A4 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731478 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC2A4 mRNA | CTD | PMID:21296121 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731479 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SLC2A4 promoter] | CTD | PMID:19654925 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731479 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC2A4 mRNA | CTD | PMID:17407152 PMID:17872374 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731479 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC2A4 protein | CTD | PMID:20181658 PMID:15050417 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731479 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC2A4 mRNA | CTD | PMID:20181658 PMID:16615095 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC2A4 mRNA | CTD | PMID:15644576 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731479 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC2A4 mRNA | CTD | PMID:17872374 PMID:17407152 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731479 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC2A4 protein | CTD | PMID:15050417 PMID:20181658 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731479 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC2A4 mRNA | CTD | PMID:16615095 PMID:20181658 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731479 | 6480464 | Forskolin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of SLC2A4 mRNA]; more ... | CTD | PMID:17407152 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731479 | 6480464 | CEBPA protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC2A4 mRNA]; more ... | CTD | PMID:16615095 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731479 | 6480464 | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC2A4 mRNA]; more ... | CTD | PMID:20181658 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:731478 | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; more ... | CTD | PMID:20165829 |
| 2-amino-2-deoxy-D-glucopyranose | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of SLC2A4 protein; more ... | CTD | PMID:20165829 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; more ... | CTD | PMID:20165829 |
| 2-amino-2-deoxy-D-glucopyranose | increases uptake | ISO | RGD:731479 | 6480464 | SLC2A4 protein results in increased uptake of Glucosamine | CTD | PMID:19373748 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:731479 | 6480464 | Glucosamine inhibits the reaction [SLC2A4 protein results in increased uptake of Glucose]; more ... | CTD | PMID:19373748 |
| 2-amino-2-deoxy-D-glucopyranose | decreases expression | ISO | RGD:731478 | 6480464 | Glucosamine results in decreased expression of SLC2A4 mRNA; more ... | CTD | PMID:20165829 |
| 2-deoxy-D-glucose | multiple interactions | EXP | | 6480464 | [Indinavir results in decreased activity of SLC2A4 protein] inhibits the reaction [resveratrol results in increased uptake of Deoxyglucose]; more ... | CTD | PMID:18601907 |
| 2-deoxy-D-glucose | multiple interactions | ISO | RGD:731479 | 6480464 | [arsenite affects the localization of SLC2A4 protein] which results in increased uptake of Deoxyglucose | CTD | PMID:14511371 |
| 2-deoxy-D-glucose | increases uptake | ISO | RGD:731479 | 6480464 | SLC2A4 protein results in increased uptake of Deoxyglucose | CTD | PMID:19477051 |
| 2-deoxy-D-glucose | multiple interactions | ISO | RGD:731479 | 6480464 | mangiferin promotes the reaction [SLC2A4 protein results in increased uptake of Deoxyglucose]; more ... | CTD | PMID:19477051 |
| 3,3',5'-triiodothyronine | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Triiodothyronine, Reverse results in decreased expression of SLC2A4 mRNA]; more ... | CTD | PMID:17198541 |
| 3,3',5'-triiodothyronine | decreases expression | EXP | | 6480464 | Triiodothyronine, Reverse results in decreased expression of SLC2A4 mRNA | CTD | PMID:17198541 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:731478 | 6480464 | [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLC2A4 mRNA; more ... | CTD | PMID:19186324 |
| 4-coumaric acid | increases expression | ISO | RGD:731479 | 6480464 | 4-coumaric acid results in increased expression of SLC2A4 mRNA | CTD | PMID:21870829 |
| 4-methyl-2-oxopentanoic acid | multiple interactions | ISO | RGD:731479 | 6480464 | [alpha-ketoisocaproic acid co-treated with monomethyl succinate] inhibits the reaction [Palmitates results in decreased expression of SLC2A4 mRNA] | CTD | PMID:21802492 |
| 4-phenylbutyric acid | multiple interactions | ISO | RGD:731478 | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; more ... | CTD | PMID:20165829 |
| 4-phenylbutyric acid | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; more ... | CTD | PMID:20165829 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | multiple interactions | EXP | | 6480464 | U 0126 inhibits the reaction [AICA ribonucleotide results in increased localization of SLC2A4 protein]; more ... | CTD | PMID:11978788 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | multiple interactions | ISO | RGD:731479 | 6480464 | AICA ribonucleotide inhibits the reaction [Palmitates results in decreased expression of SLC2A4 mRNA] | CTD | PMID:21802492 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | increases localization | EXP | | 6480464 | AICA ribonucleotide results in increased localization of SLC2A4 protein | CTD | PMID:11978788 |
| 9-cis-retinoic acid | increases expression | EXP | | 6480464 | alitretinoin results in increased expression of SLC2A4 protein | CTD | PMID:16273324 PMID:18063688 |
| 9-cis-retinoic acid | increases expression | EXP | | 6480464 | alitretinoin results in increased expression of SLC2A4 protein | CTD | PMID:18063688 PMID:16273324 |
| 9-cis-retinoic acid | increases expression | EXP | | 6480464 | alitretinoin results in increased expression of SLC2A4 mRNA | CTD | PMID:16273324 |
| acarbose | increases expression | EXP | | 6480464 | Acarbose results in increased expression of SLC2A4 mRNA; more ... | CTD | PMID:1767839 |
| aflatoxin B1 | decreases expression | ISO | RGD:731478 | 6480464 | Aflatoxin B1 results in decreased expression of SLC2A4 mRNA | CTD | PMID:21641981 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:731478 | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; more ... | CTD | PMID:20165829 |
| aldehydo-D-glucosamine | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of SLC2A4 protein; more ... | CTD | PMID:20165829 |
| aldehydo-D-glucosamine | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; more ... | CTD | PMID:20165829 |
| aldehydo-D-glucosamine | increases uptake | ISO | RGD:731479 | 6480464 | SLC2A4 protein results in increased uptake of Glucosamine | CTD | PMID:19373748 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:731479 | 6480464 | Glucosamine inhibits the reaction [SLC2A4 protein results in increased uptake of Glucose]; more ... | CTD | PMID:19373748 |
| aldehydo-D-glucosamine | decreases expression | ISO | RGD:731478 | 6480464 | Glucosamine results in decreased expression of SLC2A4 mRNA; more ... | CTD | PMID:20165829 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of SLC2A4 protein | CTD | PMID:16273324 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of SLC2A4 mRNA | CTD | PMID:16483693 |
| arsenite(3-) | affects localization | EXP | | 6480464 | arsenite affects the localization of SLC2A4 protein | CTD | PMID:17038550 |
| arsenite(3-) | multiple interactions | ISO | RGD:731479 | 6480464 | arsenite inhibits the reaction [INS1 protein affects the localization of SLC2A4 protein] | CTD | PMID:17520061 |
| arsenite(3-) | affects localization | ISO | RGD:731479 | 6480464 | arsenite affects the localization of SLC2A4 protein | CTD | PMID:14511371 PMID:15276423 |
| arsenite(3-) | multiple interactions | ISO | RGD:731479 | 6480464 | [arsenite affects the localization of SLC2A4 protein] which results in increased uptake of Deoxyglucose | CTD | PMID:14511371 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:731479 | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to SLC2A4 promoter] | CTD | PMID:19654925 |
| benzo[a]pyrene | decreases expression | ISO | RGD:731479 | 6480464 | Benzo(a)pyrene results in decreased expression of SLC2A4 mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:731479 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of SLC2A4 mRNA | CTD | PMID:21715664 |
| berberine | multiple interactions | EXP | | 6480464 | Berberine inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of SLC2A4 protein] | CTD | PMID:19080170 |
| beta-carotene | decreases expression | ISO | RGD:731479 | 6480464 | beta Carotene results in decreased expression of SLC2A4 mRNA | CTD | PMID:21569430 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:731478 | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; more ... | CTD | PMID:20165829 |
| beta-D-glucosamine | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of SLC2A4 protein; more ... | CTD | PMID:20165829 |
| beta-D-glucosamine | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; more ... | CTD | PMID:20165829 |
| beta-D-glucosamine | increases uptake | ISO | RGD:731479 | 6480464 | SLC2A4 protein results in increased uptake of Glucosamine | CTD | PMID:19373748 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:731479 | 6480464 | Glucosamine inhibits the reaction [SLC2A4 protein results in increased uptake of Glucose]; more ... | CTD | PMID:19373748 |
| beta-D-glucosamine | decreases expression | ISO | RGD:731478 | 6480464 | Glucosamine results in decreased expression of SLC2A4 mRNA; more ... | CTD | PMID:20165829 |
| bezafibrate | multiple interactions | ISO | RGD:731479 | 6480464 | Bezafibrate inhibits the reaction [Palmitates results in decreased expression of SLC2A4 mRNA] | CTD | PMID:21802492 |
| bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate affects the localization of SLC2A4 protein] | CTD | PMID:21911000 |
| bis(2-ethylhexyl) phthalate | affects localization | EXP | | 6480464 | Diethylhexyl Phthalate affects the localization of SLC2A4 protein | CTD | PMID:21911000 |
| bisphenol A | increases expression | ISO | RGD:731479 | 6480464 | bisphenol A results in increased expression of SLC2A4 protein | CTD | PMID:14707028 |
| bisphenol A | multiple interactions | EXP | | 6480464 | bisphenol A results in decreased expression of and affects the localization of SLC2A4 protein | CTD | PMID:23424204 |
| butan-1-ol | multiple interactions | EXP | | 6480464 | 1-Butanol inhibits the reaction [AICA ribonucleotide results in increased localization of SLC2A4 protein] | CTD | PMID:11978788 |
| calcitriol | increases expression | ISO | RGD:731478 | 6480464 | Calcitriol results in increased expression of SLC2A4 mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | ISO | RGD:731478 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of SLC2A4 mRNA | CTD | PMID:21592394 |
| capsaicin | increases expression | ISO | RGD:731479 | 6480464 | Capsaicin results in increased expression of SLC2A4 mRNA | CTD | PMID:19798065 |
| chlorogenic acid | increases expression | ISO | RGD:731479 | 6480464 | Chlorogenic Acid results in increased expression of SLC2A4 mRNA | CTD | PMID:21870829 |
| chromium atom | multiple interactions | EXP | | 6480464 | [Niacin co-treated with Chromium] promotes the reaction [SLC2A4 protein binds to CAV3 protein]; more ... | CTD | PMID:19027847 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:731479 | 6480464 | Ciguatoxins affects the expression of SLC2A4 mRNA | CTD | PMID:18353800 |
| cinnamic acid | increases expression | ISO | RGD:731479 | 6480464 | cinnamic acid results in increased expression of SLC2A4 mRNA | CTD | PMID:21870829 |
| cis-caffeic acid | increases expression | ISO | RGD:731479 | 6480464 | caffeic acid results in increased expression of SLC2A4 mRNA | CTD | PMID:21870829 |
| cobalt dichloride | decreases expression | ISO | RGD:731478 | 6480464 | cobaltous chloride results in decreased expression of SLC2A4 mRNA | CTD | PMID:12032628 |
| copper atom | decreases expression | EXP | | 6480464 | Copper results in decreased expression of SLC2A4 mRNA | CTD | PMID:22465980 |
| copper(0) | decreases expression | EXP | | 6480464 | Copper results in decreased expression of SLC2A4 mRNA | CTD | PMID:22465980 |
| corticosterone | increases expression | EXP | | 6480464 | Corticosterone results in increased expression of SLC2A4 mRNA | CTD | PMID:15755911 |
| D-glucose | multiple interactions | ISO | RGD:731479 | 6480464 | [3,3',4,5'-tetrahydroxystilbene results in increased localization of SLC2A4 protein] which results in increased uptake of Glucose | CTD | PMID:22579688 |
| D-glucose | multiple interactions | EXP | | 6480464 | ESR1 protein promotes the reaction [[resveratrol results in increased localization of SLC2A4 protein] which results in increased uptake of Glucose]; more ... | CTD | PMID:18426865 |
| D-glucose | increases uptake | ISO | RGD:731479 | 6480464 | SLC2A4 protein results in increased uptake of Glucose | CTD | PMID:19373748 PMID:19477051 |
| D-glucose | increases uptake | ISO | RGD:731479 | 6480464 | SLC2A4 protein results in increased uptake of Glucose | CTD | PMID:19477051 PMID:19373748 |
| D-glucose | multiple interactions | ISO | RGD:731479 | 6480464 | Glucosamine inhibits the reaction [SLC2A4 protein results in increased uptake of Glucose]; more ... | CTD | PMID:19373748 |
| D-glucose | increases uptake | ISO | RGD:731479 | 6480464 | SLC2A4 protein results in increased uptake of Glucose | CTD | PMID:19477051 |
| D-glucose | multiple interactions | ISO | RGD:731479 | 6480464 | MYH2 protein affects the reaction [SLC2A4 protein results in increased uptake of Glucose] | CTD | PMID:18773891 |
| D-glucose | multiple interactions | ISO | RGD:731479 | 6480464 | mangiferin promotes the reaction [SLC2A4 protein results in increased uptake of Glucose]; more ... | CTD | PMID:19477051 |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of SLC2A4 mRNA | CTD | PMID:15111496 |
| D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of SLC2A4 mRNA | CTD | PMID:1727734 |
| desferrioxamine B | decreases expression | ISO | RGD:731478 | 6480464 | Deferoxamine results in decreased expression of SLC2A4 mRNA | CTD | PMID:12032628 |
| dexamethasone | multiple interactions | ISO | RGD:731479 | 6480464 | bis(alpha-furancarboxylato)oxovanadium(IV) inhibits the reaction [Dexamethasone results in decreased expression of SLC2A4 mRNA] | CTD | PMID:18812026 |
| dexamethasone | multiple interactions | ISO | RGD:731478 | 6480464 | [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLC2A4 mRNA; more ... | CTD | PMID:19186324 |
| dexamethasone | decreases expression | ISO | RGD:731479 | 6480464 | Dexamethasone results in decreased expression of SLC2A4 mRNA | CTD | PMID:18812026 |
| diazoxide | decreases expression | EXP | | 6480464 | Isoproterenol results in decreased expression of SLC2A4 protein | CTD | PMID:19826179 |
| dimercaprol | multiple interactions | EXP | | 6480464 | Dimercaprol inhibits the reaction [oxophenylarsine inhibits the reaction [INS protein results in decreased phosphorylation of SLC2A4 protein]] | CTD | PMID:8048502 |
| dimethylarsinic acid | increases expression | EXP | | 6480464 | Cacodylic Acid results in increased expression of SLC2A4 mRNA | CTD | PMID:17720352 |
| dioxygen | decreases expression | ISO | RGD:731478 | 6480464 | Oxygen deficiency results in decreased expression of SLC2A4 mRNA | CTD | PMID:12032628 |
| dopamine | decreases expression | EXP | | 6480464 | Dopamine results in decreased expression of SLC2A4 mRNA | CTD | PMID:21983523 |
| doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of SLC2A4 mRNA | CTD | PMID:19915844 |
| ethanol | increases expression | ISO | RGD:731479 | 6480464 | Ethanol results in increased expression of SLC2A4 mRNA | CTD | PMID:19167417 |
| eugenol | increases expression | ISO | RGD:731479 | 6480464 | Eugenol results in increased expression of SLC2A4 mRNA | CTD | PMID:21870829 |
| eugenol | increases expression | EXP | | 6480464 | Eugenol results in increased expression of SLC2A4 mRNA | CTD | PMID:20724125 |
| fenoldopam | decreases expression | EXP | | 6480464 | Fenoldopam results in decreased expression of SLC2A4 mRNA | CTD | PMID:21983523 |
| ferulic acid | increases expression | ISO | RGD:731479 | 6480464 | ferulic acid results in increased expression of SLC2A4 mRNA | CTD | PMID:21870829 |
| fructose | decreases expression | ISO | RGD:731478 | 6480464 | Fructose results in decreased expression of SLC2A4 mRNA | CTD | PMID:18063403 |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of SLC2A4 mRNA | CTD | PMID:15111496 |
| fulvestrant | multiple interactions | EXP | | 6480464 | fulvestrant inhibits the reaction [[resveratrol results in increased localization of SLC2A4 protein] which results in increased uptake of Glucose] | CTD | PMID:18426865 |
| genistein | multiple interactions | EXP | | 6480464 | Genistein inhibits the reaction [AICA ribonucleotide results in increased localization of SLC2A4 protein] | CTD | PMID:11978788 |
| glucose | multiple interactions | ISO | RGD:731479 | 6480464 | [3,3',4,5'-tetrahydroxystilbene results in increased localization of SLC2A4 protein] which results in increased uptake of Glucose | CTD | PMID:22579688 |
| glucose | multiple interactions | EXP | | 6480464 | ESR1 protein promotes the reaction [[resveratrol results in increased localization of SLC2A4 protein] which results in increased uptake of Glucose]; more ... | CTD | PMID:18426865 |
| glucose | increases uptake | ISO | RGD:731479 | 6480464 | SLC2A4 protein results in increased uptake of Glucose | CTD | PMID:19373748 PMID:19477051 |
| glucose | increases uptake | ISO | RGD:731479 | 6480464 | SLC2A4 protein results in increased uptake of Glucose | CTD | PMID:19477051 PMID:19373748 |
| glucose | multiple interactions | ISO | RGD:731479 | 6480464 | Glucosamine inhibits the reaction [SLC2A4 protein results in increased uptake of Glucose]; more ... | CTD | PMID:19373748 |
| glucose | increases uptake | ISO | RGD:731479 | 6480464 | SLC2A4 protein results in increased uptake of Glucose | CTD | PMID:19477051 |
| glucose | multiple interactions | ISO | RGD:731479 | 6480464 | MYH2 protein affects the reaction [SLC2A4 protein results in increased uptake of Glucose] | CTD | PMID:18773891 |
| glucose | multiple interactions | ISO | RGD:731479 | 6480464 | mangiferin promotes the reaction [SLC2A4 protein results in increased uptake of Glucose]; more ... | CTD | PMID:19477051 |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of SLC2A4 mRNA | CTD | PMID:15111496 |
| glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of SLC2A4 mRNA | CTD | PMID:1727734 |
| haloperidol | increases expression | ISO | RGD:731478 | 6480464 | Haloperidol results in increased expression of SLC2A4 mRNA | CTD | PMID:16002093 |
| hemin | multiple interactions | EXP | | 6480464 | chromium mesoporphyrin inhibits the reaction [Hemin inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 protein]] | CTD | PMID:19190261 |
| indinavir | multiple interactions | EXP | | 6480464 | [Indinavir results in decreased activity of SLC2A4 protein] inhibits the reaction [resveratrol results in increased uptake of Deoxyglucose] | CTD | PMID:18601907 |
| isoprenaline | decreases expression | EXP | | 6480464 | Isoproterenol results in decreased expression of SLC2A4 protein | CTD | PMID:19826179 |
| L-ascorbic acid | increases expression | ISO | RGD:731479 | 6480464 | Ascorbic Acid results in increased expression of SLC2A4 mRNA | CTD | PMID:20122894 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate affects the localization of SLC2A4 protein] | CTD | PMID:21911000 |
| mangiferin | multiple interactions | ISO | RGD:731479 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [mangiferin promotes the reaction [SLC2A4 protein results in increased uptake of Deoxyglucose]]; more ... | CTD | PMID:19477051 |
| mangiferin | increases expression | ISO | RGD:731479 | 6480464 | mangiferin results in increased expression of SLC2A4 mRNA | CTD | PMID:19477051 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Triiodothyronine, Reverse results in decreased expression of SLC2A4 mRNA] | CTD | PMID:17198541 |
| mercury atom | decreases expression | EXP | | 6480464 | Mercury results in decreased expression of SLC2A4 mRNA | CTD | PMID:22688007 |
| mercury dichloride | decreases expression | ISO | RGD:731479 | 6480464 | Mercuric Chloride results in decreased expression of SLC2A4 protein | CTD | PMID:12883084 |
| mercury(0) | decreases expression | EXP | | 6480464 | Mercury results in decreased expression of SLC2A4 mRNA | CTD | PMID:22688007 |
| metformin | multiple interactions | ISO | RGD:731478 | 6480464 | Metformin affects the reaction [Testosterone results in decreased expression of SLC2A4] | CTD | PMID:19328476 |
| metformin | decreases expression | ISO | RGD:731479 | 6480464 | Metformin results in decreased expression of SLC2A4 mRNA | CTD | PMID:23457588 |
| metformin | increases expression | ISO | RGD:731478 | 6480464 | Metformin results in increased expression of SLC2A4 mRNA | CTD | PMID:15864539 PMID:18322300 |
| metformin | increases expression | ISO | RGD:731479 | 6480464 | Metformin results in increased expression of SLC2A4 mRNA | CTD | PMID:21870829 |
| metformin | multiple interactions | EXP | | 6480464 | Metformin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of SLC2A4 protein] | CTD | PMID:19080170 |
| metformin | increases expression | EXP | | 6480464 | Metformin results in increased expression of SLC2A4 mRNA | CTD | PMID:20724125 |
| metformin | increases expression | ISO | RGD:731478 | 6480464 | Metformin results in increased expression of SLC2A4 protein | CTD | PMID:15864539 |
| metformin | increases expression | ISO | RGD:731478 | 6480464 | Metformin results in increased expression of SLC2A4 mRNA | CTD | PMID:18322300 PMID:15864539 |
| metformin | increases expression | ISO | RGD:731478 | 6480464 | Metformin results in increased expression of SLC2A4 mRNA | CTD | PMID:18322300 |
| methyl pyruvate | multiple interactions | ISO | RGD:731479 | 6480464 | methyl pyruvate inhibits the reaction [Palmitates results in decreased expression of SLC2A4 mRNA]; more ... | CTD | PMID:21802492 |
| mirtazapine | increases expression | ISO | RGD:731478 | 6480464 | mirtazapine results in increased expression of SLC2A4 mRNA | CTD | PMID:16002093 |
| naloxone | multiple interactions | EXP | | 6480464 | Naloxone inhibits the reaction [Tramadol inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 protein]] | CTD | PMID:11723065 |
| nicotinic acid | multiple interactions | EXP | | 6480464 | [Niacin co-treated with Chromium] promotes the reaction [SLC2A4 protein binds to CAV3 protein]; more ... | CTD | PMID:19027847 |
| nimesulide | increases expression | ISO | RGD:731479 | 6480464 | nimesulide results in increased expression of SLC2A4 mRNA; more ... | CTD | PMID:16447059 |
| nimesulide | multiple interactions | ISO | RGD:731479 | 6480464 | [nimesulide results in increased expression of SLC2A4 protein] which results in increased uptake of Hexoses | CTD | PMID:16447059 |
| olanzapine | increases expression | ISO | RGD:731478 | 6480464 | olanzapine results in increased expression of SLC2A4 mRNA | CTD | PMID:16002093 |
| picolinic acid | affects localization | ISO | RGD:731479 | 6480464 | picolinic acid affects the localization of SLC2A4 protein | CTD | PMID:19195868 PMID:20721637 |
| plumbagin | multiple interactions | EXP | | 6480464 | plumbagin inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 protein]; more ... | CTD | PMID:22960630 |
| pregnenolone 16alpha-carbonitrile | increases expression | ISO | RGD:731479 | 6480464 | Pregnenolone Carbonitrile results in increased expression of SLC2A4 mRNA | CTD | PMID:22698814 |
| prostaglandin J2 | multiple interactions | EXP | | 6480464 | 9-deoxy-delta-9-prostaglandin D2 promotes the reaction [PPARG protein alternative form results in decreased activity of SLC2A4 promoter] | CTD | PMID:12777391 |
| pyruvic acid | multiple interactions | ISO | RGD:731479 | 6480464 | Pyruvic Acid inhibits the reaction [Palmitates results in decreased expression of SLC2A4 mRNA] | CTD | PMID:21802492 |
| raloxifene | increases expression | ISO | RGD:731478 | 6480464 | Raloxifene results in increased expression of SLC2A4 mRNA | CTD | PMID:19432593 |
| resveratrol | affects expression | EXP | | 6480464 | resveratrol affects the expression of SLC2A4 protein | CTD | PMID:17346750 |
| resveratrol | multiple interactions | EXP | | 6480464 | [Indinavir results in decreased activity of SLC2A4 protein] inhibits the reaction [resveratrol results in increased uptake of Deoxyglucose]; more ... | CTD | PMID:18601907 |
| resveratrol | decreases expression | ISO | RGD:731479 | 6480464 | resveratrol results in decreased expression of SLC2A4 mRNA | CTD | PMID:21109418 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of SLC2A4 protein | CTD | PMID:18266981 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Streptozocin inhibits the reaction [CAV3 protein binds to SLC2A4 protein]]; more ... | CTD | PMID:18266981 |
| resveratrol | affects localization | EXP | | 6480464 | resveratrol affects the localization of SLC2A4 protein | CTD | PMID:18266981 PMID:22569348 |
| resveratrol | increases localization | EXP | | 6480464 | resveratrol results in increased localization of SLC2A4 protein | CTD | PMID:18426865 |
| resveratrol | affects localization | EXP | | 6480464 | resveratrol affects the localization of SLC2A4 protein | CTD | PMID:22569348 |
| resveratrol | multiple interactions | EXP | | 6480464 | ESR1 protein promotes the reaction [[resveratrol results in increased localization of SLC2A4 protein] which results in increased uptake of Glucose]; more ... | CTD | PMID:18426865 |
| resveratrol | decreases expression | ISO | RGD:731479 | 6480464 | resveratrol results in decreased expression of SLC2A4 protein | CTD | PMID:18555852 |
| resveratrol | affects localization | ISO | RGD:731479 | 6480464 | resveratrol affects the localization of SLC2A4 protein | CTD | PMID:22569348 |
| rosiglitazone | decreases expression | EXP | | 6480464 | rosiglitazone results in decreased expression of SLC2A4 mRNA | CTD | PMID:19211718 |
| rosiglitazone | increases expression | ISO | RGD:731479 | 6480464 | rosiglitazone results in increased expression of SLC2A4 mRNA | CTD | PMID:18534569 |
| rosiglitazone | increases expression | ISO | RGD:731478 | 6480464 | rosiglitazone results in increased expression of SLC2A4 mRNA | CTD | PMID:15864539 more ... |
| rosiglitazone | increases expression | ISO | RGD:731478 | 6480464 | rosiglitazone results in increased expression of SLC2A4 mRNA | CTD | PMID:15864539 more ... |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [PPARG protein alternative form results in decreased activity of SLC2A4 promoter] | CTD | PMID:12777391 |
| rosiglitazone | increases expression | ISO | RGD:731478 | 6480464 | rosiglitazone results in increased expression of SLC2A4 protein | CTD | PMID:15864539 |
| rosiglitazone | increases expression | ISO | RGD:731478 | 6480464 | rosiglitazone results in increased expression of SLC2A4 mRNA | CTD | PMID:18322300 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:731478 | 6480464 | rosiglitazone inhibits the reaction [[PPARG protein co-treated with RXRA protein] binds to SLC2A4 promoter] | CTD | PMID:12777391 |
| rosiglitazone | multiple interactions | ISO | RGD:731478 | 6480464 | [bexarotene co-treated with rosiglitazone] results in increased expression of SLC2A4 mRNA | CTD | PMID:10548525 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of SLC2A4 mRNA | CTD | PMID:19201733 |
| rosiglitazone | increases expression | ISO | RGD:731478 | 6480464 | rosiglitazone results in increased expression of SLC2A4 mRNA | CTD | PMID:18322300 |
| rosiglitazone | multiple interactions | ISO | RGD:731479 | 6480464 | rosiglitazone results in increased expression of and affects the localization of SLC2A4 protein | CTD | PMID:20026082 |
| rosiglitazone | multiple interactions | ISO | RGD:731478 | 6480464 | rosiglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLC2A4 mRNA] | CTD | PMID:19186324 |
| sildenafil | increases expression | ISO | RGD:731479 | 6480464 | sildenafil results in increased expression of SLC2A4 mRNA; more ... | CTD | PMID:20471953 |
| sodium azide | increases expression | ISO | RGD:731478 | 6480464 | Sodium Azide results in increased expression of SLC2A4 mRNA | CTD | PMID:17957036 |
| sodium dichromate | decreases expression | ISO | RGD:731479 | 6480464 | sodium bichromate results in decreased expression of SLC2A4 mRNA | CTD | PMID:22155349 |
| streptozocin | multiple interactions | EXP | | 6480464 | naloxonazine inhibits the reaction [valsartan inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 mRNA]]; more ... | CTD | PMID:17199717 |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of SLC2A4 protein | CTD | PMID:11723065 more ... |
| streptozocin | multiple interactions | EXP | | 6480464 | chromium mesoporphyrin inhibits the reaction [Hemin inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 protein]] | CTD | PMID:19190261 |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of SLC2A4 mRNA | CTD | PMID:11723065 more ... |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of SLC2A4 protein | CTD | PMID:11723065 more ... |
| streptozocin | multiple interactions | EXP | | 6480464 | plumbagin inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 mRNA]; more ... | CTD | PMID:22960630 |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of SLC2A4 protein | CTD | PMID:11723065 more ... |
| streptozocin | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Streptozocin inhibits the reaction [CAV3 protein binds to SLC2A4 protein]]; more ... | CTD | PMID:18266981 |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of SLC2A4 mRNA | CTD | PMID:11723065 more ... |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of SLC2A4 protein | CTD | PMID:11723065 more ... |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of SLC2A4 protein | CTD | PMID:11723065 more ... |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of SLC2A4 mRNA | CTD | PMID:20219977 more ... |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of SLC2A4 protein | CTD | PMID:12083368 more ... |
| streptozocin | multiple interactions | EXP | | 6480464 | valsartan inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 protein]; more ... | CTD | PMID:17199717 PMID:12658023 |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of SLC2A4 protein | CTD | PMID:12083368 more ... |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of SLC2A4 mRNA | CTD | PMID:17199717 more ... |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of SLC2A4 mRNA | CTD | PMID:11723065 more ... |
| streptozocin | multiple interactions | EXP | | 6480464 | Berberine inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of SLC2A4 protein]; more ... | CTD | PMID:19080170 |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of SLC2A4 protein | CTD | PMID:12083368 more ... |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of SLC2A4 mRNA | CTD | PMID:11723065 more ... |
| streptozocin | affects localization | EXP | | 6480464 | Streptozocin affects the localization of SLC2A4 protein | CTD | PMID:20363216 |
| streptozocin | multiple interactions | EXP | | 6480464 | cinnamic aldehyde inhibits the reaction [Streptozocin affects the localization of SLC2A4 protein] | CTD | PMID:20363216 |
| streptozocin | multiple interactions | EXP | | 6480464 | GHRL protein promotes the reaction [Streptozocin results in decreased expression of SLC2A4 mRNA]; more ... | CTD | PMID:20219977 |
| streptozocin | multiple interactions | EXP | | 6480464 | bis(maltolato)oxovanadium(IV) inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 protein] | CTD | PMID:12083368 |
| streptozocin | multiple interactions | EXP | | 6480464 | valsartan inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 mRNA]; more ... | CTD | PMID:12658023 PMID:17199717 |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of SLC2A4 protein | CTD | PMID:11723065 more ... |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of SLC2A4 mRNA | CTD | PMID:20219977 more ... |
| streptozocin | affects expression | EXP | | 6480464 | Streptozocin affects the expression of SLC2A4 protein | CTD | PMID:17068109 |
| streptozocin | multiple interactions | EXP | | 6480464 | Naloxone inhibits the reaction [Tramadol inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 protein]]; more ... | CTD | PMID:11723065 |
| tamoxifen | decreases expression | ISO | RGD:731478 | 6480464 | Tamoxifen results in decreased expression of SLC2A4 mRNA | CTD | PMID:19432593 |
| tamoxifen | increases expression | ISO | RGD:731478 | 6480464 | Tamoxifen results in increased expression of SLC2A4 mRNA | CTD | PMID:19432593 |
| taurine | affects localization | EXP | | 6480464 | Taurine affects the localization of SLC2A4 protein | CTD | PMID:22138235 |
| taurine | multiple interactions | EXP | | 6480464 | Taurine inhibits the reaction [Alloxan affects the localization of SLC2A4 protein] | CTD | PMID:22138235 |
| testosterone | multiple interactions | ISO | RGD:731478 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of SLC2A4 mRNA | CTD | PMID:21592394 |
| testosterone | increases expression | ISO | RGD:731478 | 6480464 | Testosterone results in increased expression of SLC2A4 mRNA | CTD | PMID:21592394 |
| testosterone | decreases expression | ISO | RGD:731478 | 6480464 | Testosterone results in decreased expression of SLC2A4 | CTD | PMID:19328476 |
| testosterone | multiple interactions | ISO | RGD:731478 | 6480464 | Metformin affects the reaction [Testosterone results in decreased expression of SLC2A4] | CTD | PMID:19328476 |
| trans-4-coumaric acid | increases expression | ISO | RGD:731479 | 6480464 | 4-coumaric acid results in increased expression of SLC2A4 mRNA | CTD | PMID:21870829 |
| trans-resveratrol | affects expression | EXP | | 6480464 | resveratrol affects the expression of SLC2A4 protein | CTD | PMID:17346750 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [Indinavir results in decreased activity of SLC2A4 protein] inhibits the reaction [resveratrol results in increased uptake of Deoxyglucose]; more ... | CTD | PMID:18601907 |
| trans-resveratrol | decreases expression | ISO | RGD:731479 | 6480464 | resveratrol results in decreased expression of SLC2A4 mRNA | CTD | PMID:21109418 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of SLC2A4 protein | CTD | PMID:18266981 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Streptozocin inhibits the reaction [CAV3 protein binds to SLC2A4 protein]]; more ... | CTD | PMID:18266981 |
| trans-resveratrol | affects localization | EXP | | 6480464 | resveratrol affects the localization of SLC2A4 protein | CTD | PMID:18266981 PMID:22569348 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | ESR1 protein promotes the reaction [[resveratrol results in increased localization of SLC2A4 protein] which results in increased uptake of Glucose]; more ... | CTD | PMID:18426865 |
| trans-resveratrol | increases localization | EXP | | 6480464 | resveratrol results in increased localization of SLC2A4 protein | CTD | PMID:18426865 |
| trans-resveratrol | affects localization | EXP | | 6480464 | resveratrol affects the localization of SLC2A4 protein | CTD | PMID:22569348 |
| trans-resveratrol | decreases expression | ISO | RGD:731479 | 6480464 | resveratrol results in decreased expression of SLC2A4 protein | CTD | PMID:18555852 |
| trans-resveratrol | affects localization | ISO | RGD:731479 | 6480464 | resveratrol affects the localization of SLC2A4 protein | CTD | PMID:22569348 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of SLC2A4 mRNA; more ... | CTD | PMID:11947963 |
| valproic acid | affects expression | ISO | RGD:731479 | 6480464 | Valproic Acid affects the expression of SLC2A4 mRNA | CTD | PMID:17963808 |
| valsartan | multiple interactions | EXP | | 6480464 | naloxonazine inhibits the reaction [valsartan inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 mRNA]]; more ... | CTD | PMID:17199717 |
| valsartan | multiple interactions | EXP | | 6480464 | valsartan inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 mRNA]; more ... | CTD | PMID:12658023 PMID:17199717 |
| valsartan | multiple interactions | EXP | | 6480464 | valsartan inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 mRNA]; more ... | CTD | PMID:17199717 PMID:12658023 |
| vanadium atom | decreases expression | ISO | RGD:731478 | 6480464 | Vanadium results in decreased expression of SLC2A4 mRNA | CTD | PMID:19000753 |
| vanadium(0) | decreases expression | ISO | RGD:731478 | 6480464 | Vanadium results in decreased expression of SLC2A4 mRNA | CTD | PMID:19000753 |
| vancomycin | increases expression | ISO | RGD:731479 | 6480464 | Vancomycin results in increased expression of SLC2A4 mRNA | CTD | PMID:18930951 |
| wortmannin | multiple interactions | EXP | | 6480464 | wortmannin inhibits the reaction [AICA ribonucleotide results in increased localization of SLC2A4 protein] | CTD | PMID:11978788 |
| zidovudine | affects expression | ISO | RGD:731478 | 6480464 | Zidovudine affects the expression of SLC2A4 mRNA | CTD | PMID:20032539 |